NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
NOVARTIS INDIA LTD. (BSE: 500672)
500672 Technical Analysis
2
As on 24th Dec 2024 500672 SHARE Price closed @ 950.60 and we RECOMMEND Buy for LONG-TERM with Stoploss of 871.58 & Strong Sell for SHORT-TERM with Stoploss of 1066.05 we also expect STOCK to react on Following IMPORTANT LEVELS. |
500672SHARE Price
Open | 955.00 | Change | Price | % |
High | 974.90 | 1 Day | 2.15 | 0.23 |
Low | 948.00 | 1 Week | -186.55 | -16.41 |
Close | 950.60 | 1 Month | -186.55 | -16.41 |
Volume | 3072 | 1 Year | 239.05 | 33.60 |
52 Week High 1224.00 | 52 Week Low 708.00 |
BSE INDIA Most Active Stocks
532822 | 7.47 | -0.13% |
532411 | 0.41 | 0.00% |
517001 | 0.09 | 12.50% |
511700 | 1.01 | -0.98% |
512149 | 0.88 | 0.00% |
511389 | 7.25 | -2.42% |
534690 | 7.65 | 4.79% |
532775 | 2.04 | -0.97% |
531328 | 1.05 | 0.96% |
532648 | 19.80 | -0.60% |
BSE INDIA Top Gainers Stocks
BSE INDIA Top Losers Stocks
500672 Daily Charts |
500672 Intraday Charts |
Whats New @ Bazaartrend |
500672 Free Analysis |
|
500672 Important Levels Intraday
RESISTANCE | 1002.44 |
RESISTANCE | 985.81 |
RESISTANCE | 975.54 |
RESISTANCE | 965.26 |
SUPPORT | 935.94 |
SUPPORT | 925.66 |
SUPPORT | 915.39 |
SUPPORT | 898.76 |
500672 Target April 2025
4th UP Target | 0 |
3rd UP Target | 0 |
2nd UP Target | 0 |
1st UP Target | 0 |
1st DOWN Target | 0 |
2nd DOWN Target | 0 |
3rd DOWN Target | 0 |
4th DOWN Target | 0 |
500672 Weekly Target
4th UP Target | 0.00 |
3rd UP Target | 0.00 |
2nd UP Target | 0.00 |
1st UP Target | 0.00 |
1st DOWN Target | 0.00 |
2nd DOWN Target | 0.00 |
3rd DOWN Target | 0.00 |
4th DOWN Target | 0.00 |
500672 Target2025
4th UP Target | 1457.34 |
3rd UP Target | 1237.95 |
2nd UP Target | 1102.34 |
1st UP Target | 966.73 |
1st DOWN Target | 579.78 |
2nd DOWN Target | 444.17 |
3rd DOWN Target | 308.56 |
4th DOWN Target | 89.17 |
NOVARTIS INDIA LTD. ( BSE INDIA Symbol : 500672 )
Sector : Other And Other Stocks in Same Sector
Sector : Other And Other Stocks in Same Sector
500672 Other Details
Segment | EQ | |
Market Capital | 15215699968.00 | |
Sector | Other | |
Industry | Other | |
Offical website | > echo $website ; ?> |
500672 Address
![]() |
500672 Latest News
500672 Business Profile
Novartis India Limited manufactures and sells healthcare products in India and internationally. The company offers a portfolio of prescription medicines in the areas of bone and pain, calcium portfolio, gynecology and neurosciences, oncology, primary care, and specialty medicines through healthcare professionals. It also provides generics products primarily focused on the therapeutic segments, such as anti-TB, anti-DUB, antihistamines, oncology, injectables, antibiotics, anti-ulcerants, anti-diabetes, and cardiovascular. In addition, the company offers eye care products. The company was founded in 1947 and is based in Mumbai, India. Novartis India Limited is a subsidiary of Novartis AG. Address:
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service